Mounjaro, Zepbound pour money into Eli Lilly, fueling a better-than-expected second quarter TOM MURPHY | 08/08/2024
CVS Health cuts its 2024 forecast a third time, dragged down by health insurance struggles TOM MURPHY | 07/08/2024
Drugstores tinker with new looks as their usual way of doing business faces challenges TOM MURPHY | 04/08/2024
European committee says Alzheimer’s treatment Leqembi shouldn’t get marketing approval TOM MURPHY | 26/07/2024
UnitedHealth has a strong second quarter, but cyberattack keeps it cautious on outlook for the year TOM MURPHY | 16/07/2024
Walgreens to take a hard look at underperforming stores, could shutter hundreds more TOM MURPHY | 27/06/2024
Drug shortages keep on growing. Older, injectable medicines are among the most vulnerable TOM MURPHY | 17/06/2024
Biden administration seeks to wipe consumer medical debt off most credit reports with proposed rule TOM MURPHY | 12/06/2024
Being a patient is getting harder in a strained and complex US health care system TOM MURPHY | 02/06/2024
Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, Mounjaro TOM MURPHY | 24/05/2024
Change Healthcare cyberattack was due to a lack of multifactor authentication, UnitedHealth CEO says TOM MURPHY | 02/05/2024
CVS Health chops 2024 forecast as cost struggles with Medicare Advantage persist TOM MURPHY | 01/05/2024
Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues TOM MURPHY | 30/04/2024
Cyberattack costs hit UnitedHealth in 1Q that still turns out better than expected TOM MURPHY | 16/04/2024
It’s the first drug shown to slow Alzheimer’s. Why is is it off to a slow start? TOM MURPHY | 13/04/2024
